Cargando…
Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis
BACKGROUND: The ryanodine receptors (RYRs) have been implicated in many muscular, cardiac and neurological diseases. However, there are almost no studies so far focusing on RYR genetic alterations and its roles in cancer, especially in non-small cell lung cancer (NSCLC). METHODS: The whole-exome seq...
Autores principales: | Wang, Yang, Chen, Yun, Zhang, Libin, Xiong, Jian, Xu, Lele, Cheng, Changfu, Xu, Zheyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372243/ https://www.ncbi.nlm.nih.gov/pubmed/35966320 http://dx.doi.org/10.21037/tcr-21-2395 |
Ejemplares similares
-
Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy
por: Vattemi, Gaetano Nicola Alfio, et al.
Publicado: (2022) -
The ryanodine receptor mutational characteristics and its indication for cancer prognosis
por: Wang, Fenglin, et al.
Publicado: (2022) -
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021) -
Identification of Potential Biomarkers for Ryanodine Receptor 1 (RYR1) Mutation-Associated Myopathies Using Bioinformatics Approach
por: Wang, Xi, et al.
Publicado: (2022) -
Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts
por: Goddard, C A, et al.
Publicado: (2008)